Effect of fat emulsion (Fabuless) on orocecal transit time in healthy men

References

• Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999; 282: 1530–8
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Obesity: preventing and managing the global epidemic, report of a WHO consultation on obesity, Geneva: WHO: WHO/NUD/NCD/98.1; 2000.
   Google Scholar
• Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here?. Science 2003; 299: 853–5
   PubMed Web of Science ®Google Scholar
• Burns AA, Livingstone MB, Welch RW, Dunne A, Robson PJ, Lindmark L. et al. Short-term effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-obese subjects. Int J Obes Relat Metab Disord 2000; 24: 1419–25
   PubMed Web of Science ®Google Scholar
• Burns AA, Livingstone MB, Welch RW, Dunne A, Reid CA, Rowland IR. The effects of yoghurt containing a novel fat emulsion on energy and macronutrient intakes in non-overweight, overweight and obese subjects. Int J Obes Relat Metab Disord 2001; 25: 1487–96
   PubMed Web of Science ®Google Scholar
• Burns AA, Livingstone MB, Welch RW, Dunne A, Rowland IR. Dose-response effects of a novel fat emulsion (Olibra) on energy and macronutrient intakes up to 36 h post-consumption. Eur J Clin Nutr 2002; 56: 368–77
   PubMed Web of Science ®Google Scholar
• Diepvens K, Steijns J, Zuurendonk P. Westerterp-Plantenga MS. Short-term effects of a novel fat emulsion on appetite and food intake. Physiol Behav 2008; 95: 114–7
   PubMed Web of Science ®Google Scholar
• Logan CM, McCaffrey TA, Wallace JM, Robson PJ, Welch RW, Dunne A, et al. Investigation of the medium-term effects of Olibratrade mark fat emulsion on food intake in non-obese subjects. Eur J Clin Nutr 2006; 60: 1081–91
   PubMed Web of Science ®Google Scholar
• Diepvens K, Soenen S, Steijns J, Arnold M, Westerterp-Plantenga M. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management. Int J Obes (Lond) 2007; 31: 942–9
   PubMed Web of Science ®Google Scholar
• Olsson, J, Sundberg, B, Olsson, R, Viberg, A, Yazdanpanah, N, Haenni, A.. Effect of fat emulsion on body composition; a 12-week study in overweight women on a meal replacement therapy after an initial weight loss. 2009; to be submitted.
   Google Scholar
• Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar GB. et al. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984; 86: 274–80
   PubMed Web of Science ®Google Scholar
• Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee YC, et al. The ileal brake: inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984; 25: 365–74
   PubMed Web of Science ®Google Scholar
• Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control [review]. Physiol Behav 2008; 95: 271–81
   PubMed Web of Science ®Google Scholar
• Van Citters GW, Lin HC. The ileal brake: a fifteen-year progress report. Curr Gastroenterol Rep 1999; 1: 404–9
   PubMedGoogle Scholar
• Gramatte T, Terhaag B. The variability of orocecal transit time evaluated by the salicylazosulphapyridine/sulphapyridine method. Int J Clin Pharmacol Ther Toxicol 1991; 29: 147–50
   PubMed Web of Science ®Google Scholar
• Sogni P, Chaussade S, Akue-Gohe K, Nepveux P, Homerin M, Couturier D, et al. Comparative effects of ricinoleic acid and senna on orocecal and oroanal transit time in healthy subjects. Application of the salacylazosulfapyridine method. Gastroenterol Clin Biol 1992; 16: 21–4
   PubMedGoogle Scholar
• Sunesen VH, Vedelsdal R, Kristensen HG, Christrup L, Mullertz A. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug. Eur J Pharm Sci 2005; 24: 297–303
   PubMed Web of Science ®Google Scholar
• Kellow JE, Borody TJ, Phillips SF, Haddad AC, Brown ML. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit. Gastroenterology 1986; 91: 396–400
   PubMed Web of Science ®Google Scholar
• Hansson KA, Sandberg M. Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine. Acta Pharm Suec 1973; 10: 87–92
   PubMedGoogle Scholar
• Welch I, Saunders K, Read NW. Effect of ileal and intravenous infusions of fat emulsions on feeding and satiety in human volunteers. Gastroenterology 1985; 89: 1293–7
   PubMed Web of Science ®Google Scholar
• Welch IM, Davison PA, Worlding J, Read NW. Effect of ileal infusion of lipid on jejunal motor patterns after a nutrient and nonnutrient meal. Am J Physiol 1988; 255: G800–6
   PubMed Web of Science ®Google Scholar
• Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 1995; 40: 1074–82
   PubMed Web of Science ®Google Scholar
• Holgate AM, Read NW. Effect of ileal infusion of intralipid on gastrointestinal transit, ileal flow rate, and carbohydrate absorption in humans after ingestion of a liquid meal. Gastroenterology 1985; 88: 1005–11
   PubMed Web of Science ®Google Scholar
• Keller J, Holst JJ, Layer P. Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads. Am J Physiol Gastrointest Liver Physiol 2006; 290: G704–9
   PubMed Web of Science ®Google Scholar
• Symersky, T, Kee, B, Haddeman, E, Peters, HP, Masclee, AA. Low dose ileal oil perfusion increases satiety in humans. Gastroenterology 2004;126(A60): Suppl 2.
   Google Scholar
• Maljaars J, Symersky T, Kee BC, Haddeman E, Peters HP, Masclee AA. Effect of ileal fat perfusion on satiety and hormone release in healthy volunteers. Int J Obes 2008; 32: 1633–9
   Web of Science ®Google Scholar